- Home
- BBT vs HTFL Comparison
BBT vs HTFL Comparison
Compare BBT & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | BBT | HTFL |
|---|---|---|
| Founded | 1846 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.4B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | BBT | HTFL |
|---|---|---|
| Price | $28.29 | $30.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $33.00 | ★ $39.50 |
| AVG Volume (30 Days) | 610.5K | ★ 786.5K |
| Earning Date | 01-28-2026 | 03-27-2026 |
| Dividend Yield | ★ 1.14% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $318,120,000.00 | $161,881,000.00 |
| Revenue This Year | $66.62 | $40.42 |
| Revenue Next Year | $68.43 | $22.27 |
| P/E Ratio | $298.16 | ★ N/A |
| Revenue Growth | N/A | ★ 85.70 |
| 52 Week Low | $22.27 | $25.38 |
| 52 Week High | $30.50 | $41.22 |
Technical Indicators
Market Signals| Indicator | BBT | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 59.40 | 44.92 |
| Support Level | $27.71 | $32.80 |
| Resistance Level | $29.63 | $35.98 |
| Average True Range (ATR) | 0.73 | 2.17 |
| MACD | 0.10 | -0.35 |
| Stochastic Oscillator | 57.98 | 4.78 |
Price Performance
Historical ComparisonAbout BBT Beacon Financial Corporation
Beacon Financial Corp operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.
About HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.